A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients with Essential Hypertension and Type 2 Diabetes in Asia

<div>Percentage of patients with trough BP &lt; 140/85 mm Hg by age and BMI subgroup analysis using GEE (logistic regression analysis): FAS and LOCF and number of patients with nonmissing values and used as denominator to calculate percentage. The percentages and 95% confidence intervals are shown. BMI, body mass index; FAS, full analysis set; GEE, generalized estimated equation; and LOCF, last observation carried forward.</div>

International Journal of Hypertension

fig2

Figure 2

Figure 2: A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients with Essential Hypertension and Type 2 Diabetes in Asia 